主要文件

查看所有文档

Y0001185

马兜铃酸I

Name: 马兜铃酸I
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

TR 1736

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₇H₁₁NO₇

化学文摘社编号:

313-67-7

分子量:

341.27

NACRES:

NA.24

PubChem Substance ID:

329831298

UNSPSC Code:

41116107

MDL number:

MFCD00004996

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

pharmaceutical primary standard

API family

aristolochia

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

SMILES string

COc1cccc2c1cc([N+]([O-])=O)c3c(cc4OCOc4c23)C(O)=O

InChI

1S/C17H11NO7/c1-23-12-4-2-3-8-9(12)5-11(18(21)22)14-10(17(19)20)6-13-16(15(8)14)25-7-24-13/h2-6H,7H2,1H3,(H,19,20)

InChI key

BBFQZRXNYIEMAW-UHFFFAOYSA-N

说明

General description

本品按现行药典规定交付。所有本产品相关的支持信息，包括SDS和任何产品信息宣传册，均是在药典的授权下制定和发布的。
如需进一步信息和支持，请访问现行药典网站。

Application

马兜铃酸 I EP参考标准品的预期用途是欧洲药典规定的实验室测试。

Biochem/physiol Actions

有效的磷脂酶A₂ 抑制剂，包括钙离子载体诱导的嗜中性粒细胞磷脂酶A₂ 活性。实验动物模型的肾肿瘤引发剂。

Packaging

本品按照现行药典要求提供。有关当前单位数量，请见EDQM 参考目录。

Other Notes

可能适用相应的销售限制。

Still not finding the right product?

Explore all of our products under 马兜铃酸I

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.

Heinz H Schmeiser et al.

International journal of cancer, 135(2), 502-507 (2014-06-13)

Aristolochic acid (AA) causes aristolochic acid nephropathy (AAN), first described in women in Belgium accidently prescribed Aristolochia fangchi in a slimming treatment, and also Balkan endemic nephropathy (BEN), through probable dietary contamination with Aristolochia clematitis seeds. Both nephropathies have a

Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources.

Michael Heinrich et al.

Journal of ethnopharmacology, 125(1), 108-144 (2009-06-10)

More than 100 cases of nephropathy over the last 10 years caused by the systemic and longer term application of Chinese snakeroot (Aristolochia fangchi) highlighted the risk of using preparations which contain aristolochic acids. On the other hand anecdotal evidence

A Balkan riddle's serendipitous solution.

Jon Cohen

Science (New York, N.Y.), 344(6180), 146-146 (2014-04-12)

查看所有相关文献

全球贸易项目编号

货号	GTIN
Y0001185	04061833818121